Cargando…
Oxaliplatin Causes Transient Changes in TRPM8 Channel Activity
Oxaliplatin is a third-generation platinum-based anticancer drug that is widely used as first-line treatment for colorectal carcinoma. Patients treated with oxaliplatin develop an acute peripheral pain several hours after treatment, mostly characterized by cold allodynia as well as a long-term chron...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125753/ https://www.ncbi.nlm.nih.gov/pubmed/34066977 http://dx.doi.org/10.3390/ijms22094962 |